Gufic BioSciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 204.07 | 195.87 | 202.20 |
| Operating Expense | 167.03 | 160.77 | 165.32 |
| Net Profit | 20.86 | 20.05 | 22.26 |
| Net Profit Margin | 10.22 | 10.24 | 11.01 |
| Earning Per Share | 2.08 | 2 | 2.23 |
| EBIDTA | 36.79 | 35.34 | 36.78 |
| Effective Tax Rate | 18.90 | 20.79 | 19.52 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 204.07 |
| Operating Expense | 167.03 |
| Net Profit | 20.86 |
| Net Profit Margin | 10.22 |
| Earning Per Share | 2.08 |
| EBIDTA | 36.79 |
| Effective Tax Rate | 18.90 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 806.67 | 690.62 | 779.16 |
| Operating Expenses Annual | 660.79 | 555.97 | 631.13 |
| Operating Profit Annual | 148.05 | 137.23 | 151.13 |
| Interest Annual | 15.36 | 8.22 | 5.37 |
| Depreciation | 9.89 | 15.52 | 13.97 |
| Net Profit Annual | 86.14 | 79.70 | 95.84 |
| Tax Annual | 29.54 | 27.02 | 31.00 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 806.67 |
| Operating Expenses Annual | 660.79 |
| Operating Profit Annual | 148.05 |
| Interest Annual | 15.36 |
| Depreciation | 9.89 |
| Net Profit Annual | 86.14 |
| Tax Annual | 29.54 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 28.60 | 11.61 | 6.20 |
| Cash Flow from Operations | -7.46 | -26.59 | 106.24 |
| Cash Flow from Investing | -102.40 | -190.73 | -94.59 |
| Cash Flow from Financing | 82.38 | 234.31 | -6.24 |
| Cash Flow at the End | 1.13 | 28.60 | 11.61 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 28.60 |
| Cash Flow from Operations | -7.46 |
| Cash Flow from Investing | -102.40 |
| Cash Flow from Financing | 82.38 |
| Cash Flow at the End | 1.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 18.35 | 19.87 | 19.40 |
| PBIT Margin (%) | 16.24 | 16.64 | 16.97 |
| PBT Margin (%) | 15.18 | 14.62 | 13.81 |
| Net PROFIT Margin (%) | 10.68 | 11.54 | 12.30 |
| Return On Networth / Equity (%) | 19.57 | 25.84 | 43.31 |
| Return On Networth /Employed (%) | 16.52 | 21.87 | 43.99 |
| Return On Assets (%) | 10.89 | 15.12 | 31.86 |
| Total Debt / Equity (X) | 0.76 | 0.65 | 0.28 |
| Asset Turnover Ratio (%) | 1.02 | 1.31 | 2.59 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 18.35 |
| PBIT Margin (%) | 16.24 |
| PBT Margin (%) | 15.18 |
| Net PROFIT Margin (%) | 10.68 |
| Return On Networth / Equity (%) | 19.57 |
| Return On Networth /Employed (%) | 16.52 |
| Return On Assets (%) | 10.89 |
| Total Debt / Equity (X) | 0.76 |
| Asset Turnover Ratio (%) | 1.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 158.89 | 159.57 | 115.17 |
| Total Current Assets Annual | 600.47 | 464.11 | 320.75 |
| Non Current Assets Annual | 492.07 | 397.05 | 200.65 |
| Total Shareholders Funds Annual | 532.56 | 347.81 | 269.12 |
| Total Assets Annual | 1,092.54 | 861.16 | 521.40 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 158.89 |
| Total Current Assets Annual | 600.47 |
| Non Current Assets Annual | 492.07 |
| Total Shareholders Funds Annual | 532.56 |
| Total Assets Annual | 1,092.54 |
EPS (INR)
Expected
2.08
Reported
2.08
Surprise
0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
Sep 2023
EPS beaten by 0.45%
